http://www.cnr.it/ontology/cnr/individuo/prodotto/ID312102
Stromal cell-derived factor-1-30A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance (Articolo in rivista)
- Type
- Label
- Stromal cell-derived factor-1-30A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance (Articolo in rivista) (literal)
- Anno
- 2014-01-01T00:00:00+01:00 (literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#doi
- 10.2459/JCM.0000000000000068 (literal)
- Alternative label
Andrea Borghini, Silverio Sbrana, Cecilia Vecoli, Antonella Mercuri,
Stefano Turchi, Clara Carpeggiani, Antonio L'Abbate and Maria G. Andreassi (2014)
Stromal cell-derived factor-1-30A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance
in Journal of cardiovascular medicine (Hagerstown, Md. : Online)
(literal)
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#autori
- Andrea Borghini, Silverio Sbrana, Cecilia Vecoli, Antonella Mercuri,
Stefano Turchi, Clara Carpeggiani, Antonio L'Abbate and Maria G. Andreassi (literal)
- Pagina inizio
- Pagina fine
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#numeroVolume
- Rivista
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#pagineTotali
- Note
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#affiliazioni
- Institute of Clinical Physiology, CNR, via Moruzzi 1, 56124 Pisa, Italy (literal)
- Titolo
- Stromal cell-derived factor-1-30A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance (literal)
- Abstract
- Aim: Genome-wide association studies have identified single-nucleotide polymorphisms at the 10q11 locus as risk factors for myocardial infarction (MI). This locus lies upstream (?80 kb) of the stromal cell-derived factor-1 (SDF1) gene that codes for a chemokine with protective atherogenetic effects and with a major role in the mobilization, homing, and differentiation of endothelial progenitor cells (EPCs). The purpose of this study was to investigate the possible association of SDF1-3'A polymorphism, that upregulates SDF1 protein expression, with MI as well as early endothelial dysfunction and atherosclerosis in young healthy subjects.
Methods: 200 patients (181 men age 57.3+/-7.7 years) and 230 healthy controls (96 men, age 52+/-11.9 years) were
recruited to investigate the association between MI and SDF1-30A polymorphism. The relationship between
SDF1-3'A polymorphism, brachial artery flow-mediated dilation, and the number of circulating EPCs was examined in 50 healthy young adults.
Results: A significant difference in SDF1-3'A genotype distribution was observed between patients and controls
(P=0.006). Patients carrying the A allele had a significantly reduced MI risk compared with subjects with GG
genotype (odds ratio=0.5, 95% CI=0.3-0.9, P=0.001). SDF1-3'A polymorphism presented a significant
interaction with other cardiovascular risk factors (Pinteraction<0. 0001). Controls carrying the A allele showed
significantly higher flow-mediated dilation (13.9+/-4.9 vs 10.8+/-4.3, P=0.03) and significantly higher values of EPCs (0.029+/-0.009 vs 0.022+/-0.008, P=0.02) compared with GG homozygotes.
Conclusion: SDF1-3'A polymorphism is associated with a decreased risk of MI and early endothelial dysfunction, strongly confirming the important atherogenic role of the SDF1 gene at the clinical level. (literal)
- Prodotto di
- Autore CNR
- Insieme di parole chiave
Incoming links:
- Autore CNR di
- Prodotto
- Http://www.cnr.it/ontology/cnr/pubblicazioni.owl#rivistaDi
- Insieme di parole chiave di